{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:11:05Z","timestamp":1765296665210,"version":"3.46.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Society for Alcohol"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004406","UM1TR004406"],"award-info":[{"award-number":["UM1TR004406","UM1TR004406"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-025-06980-y","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T03:11:55Z","timestamp":1765249915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of dietary stimulation on acute changes in GLP-1, alcohol responses, craving, and attentional bias: a randomized, placebo-controlled laboratory study"],"prefix":"10.1007","author":[{"given":"Michael P.","family":"Bremmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimikaye B.","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle S.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd E.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian S.","family":"Hendershot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"2","key":"6980_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1210\/en.2011-1443","volume":"153","author":"AL Alhadeff","year":"2012","unstructured":"Alhadeff AL, Rupprecht LE, Hayes MR (2012) GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153(2):647\u2013658","journal-title":"Endocrinology"},{"key":"6980_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104642","author":"C Aran\u00e4s","year":"2023","unstructured":"Aran\u00e4s C, Edvardsson CE, Shevchouk OT, Zhang Q, Witley S, Sk\u00f6ldheden SB, Zentveld L, Vall\u00f6f D, Tufvesson-Alm M, Jerlhag E (2023) Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104642","journal-title":"EBioMedicine"},{"issue":"3","key":"6980_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1530-0277.1995.tb01554.x","volume":"19","author":"MJ Bohn","year":"1995","unstructured":"Bohn MJ, Krahn DD, Staehler BA (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19(3):600\u2013606","journal-title":"Alcohol Clin Exp Res"},{"key":"6980_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.drugalcdep.2017.07.033","volume":"180","author":"S Bouhlal","year":"2017","unstructured":"Bouhlal S, Ellefsen KN, Sheskier MB, Singley E, Pirard S, Gorelick DA, Huestis MA, Leggio L (2017) Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses. Drug Alcohol Depend 180:68\u201375","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"6980_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1037\/pha0000176","volume":"26","author":"SJ Boyd","year":"2018","unstructured":"Boyd SJ, Corbin WR (2018) Faster alcohol metabolism is associated with increased stimulation and within session consumption. Exp Clin Psychopharmacol 26(2):168","journal-title":"Exp Clin Psychopharmacol"},{"key":"6980_CR6","doi-asserted-by":"crossref","unstructured":"Bremmer M, Hendershot C (2023) Social media as pharmacovigilance: The potential for patient reports to inform clinical research on glucagon-like peptide 1 (GLP-1) receptor agonists for substance use disorders. J. of\u00a0Stud. Alcohol Drugs (in press)","DOI":"10.15288\/jsad.23-00318"},{"issue":"8","key":"6980_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1530-0277.2006.00155.x","volume":"30","author":"J Brick","year":"2006","unstructured":"Brick J (2006) Standardization of alcohol calculations in research. Alcohol Clin Exp Res 30(8):1276\u20131287","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"6980_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s42255-021-00344-4","volume":"3","author":"DI Brierley","year":"2021","unstructured":"Brierley DI, Holt MK, Singh A, de Araujo A, McDougle M, Vergara M, Afaghani MH, Lee SJ, Scott K, Maske C (2021) Central and peripheral GLP-1 systems independently suppress eating. Nat Metab 3(2):258\u2013273","journal-title":"Nat Metab"},{"issue":"8","key":"6980_CR9","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1210\/jc.2012-1475","volume":"97","author":"RJ Brown","year":"2012","unstructured":"Brown RJ, Rother KI (2012) Non-nutritive sweeteners and their role in the gastrointestinal tract. J Clin Endocrinol Metab 97(8):2597\u20132605","journal-title":"J Clin Endocrinol Metab"},{"key":"6980_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107312","volume":"207","author":"N Bruns Vi","year":"2024","unstructured":"Bruns Vi N, Tressler EH, Vendruscolo LF, Leggio L, Farokhnia M (2024) IUPHAR review \u2013 Glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target. Pharmacol Res 207:107312","journal-title":"Pharmacol Res"},{"issue":"9","key":"6980_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1365-2982.2009.01317.x","volume":"21","author":"V Bucinskaite","year":"2009","unstructured":"Bucinskaite V, Tolessa T, Pedersen J, Rydqvist B, Zerihun L, Holst J, Hellstr\u00f6m PM (2009) Receptor-mediated activation of gastric vagal afferents by glucagon\u2010like peptide\u20101 in the rat. Neurogastroenterol Motil 21(9):978\u2013e978","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"6980_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3945\/ajcn.2009.28095","volume":"90","author":"PD Cani","year":"2009","unstructured":"Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90(5):1236\u20131243","journal-title":"Am J Clin Nutr"},{"key":"6980_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jff.2017.06.015","volume":"35","author":"MM Celestino","year":"2017","unstructured":"Celestino MM, Gomes AC, Botelho PB, Gambero A, Mesquita LM, Vilegas W, Ribeiro ML, Mota JF (2017) South American herbal extracts reduce food intake through modulation of gastrointestinal hormones in overweight and obese women. J Funct Foods 35:555\u2013563","journal-title":"J Funct Foods"},{"issue":"9","key":"6980_CR14","first-page":"3312","volume":"9","author":"HS Chow","year":"2003","unstructured":"Chow HS, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y, Alberts DS (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of Epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 9(9):3312\u20133319","journal-title":"Clin Cancer Res"},{"key":"6980_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170671","author":"V Chuong","year":"2023","unstructured":"Chuong V, Farokhnia M, Khom S, Pince CL, Elvig SK, Vlkolinsky R, Marchette RC, Koob GF, Roberto M, Vendruscolo LF (2023) The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.170671","journal-title":"JCI Insight"},{"issue":"8s2","key":"6980_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1360-0443.95.8s2.5.x","volume":"95","author":"H De Wit","year":"2000","unstructured":"De Wit H (2000) Laboratory-based assessment of alcohol craving in social drinkers. Addiction 95(8s2):165\u2013169","journal-title":"Addiction"},{"issue":"14","key":"6980_CR17","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","volume":"32","author":"SL Dickson","year":"2012","unstructured":"Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP (2012) The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 32(14):4812\u20134820","journal-title":"J Neurosci"},{"key":"6980_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00213-004-1906-7","volume":"176","author":"T Duka","year":"2004","unstructured":"Duka T, Townshend JM (2004) The priming effect of alcohol pre-load on attentional bias to alcohol-related stimuli. Psychopharmacology 176:353\u2013361","journal-title":"Psychopharmacology"},{"issue":"10","key":"6980_CR19","doi-asserted-by":"publisher","first-page":"e77284","DOI":"10.1371\/journal.pone.0077284","volume":"8","author":"E Egecioglu","year":"2013","unstructured":"Egecioglu E, Engel JA, Jerlhag E (2013a) The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. PLoS One 8(10):e77284","journal-title":"PLoS One"},{"key":"6980_CR20","doi-asserted-by":"crossref","unstructured":"Egecioglu E, Engel JA, Jerlhag E (2013b) The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLoS ONE, 8(7), e69010","DOI":"10.1371\/journal.pone.0069010"},{"issue":"8","key":"6980_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.psyneuen.2012.11.009","volume":"38","author":"E Egecioglu","year":"2013","unstructured":"Egecioglu E, Steensland P, Fredriksson I, Feltmann K, Engel JA, Jerlhag E (2013c) The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology 38(8):1259\u20131270","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"6980_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11154-014-9288-6","volume":"15","author":"A Everard","year":"2014","unstructured":"Everard A, Cani PD (2014) Gut microbiota and GLP-1. Rev Endocr Metab Disord 15(3):189\u2013196","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"6980_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13211","volume":"27","author":"M Farokhnia","year":"2022","unstructured":"Farokhnia M, Browning BD, Crozier ME, Sun H, Akhlaghi F, Leggio L (2022) The glucagon-like peptide\u20101 system is modulated by acute and chronic alcohol exposure: findings from human laboratory experiments and a post\u2010mortem brain study. Addict Biol 27(5):e13211","journal-title":"Addict Biol"},{"key":"6980_CR24","doi-asserted-by":"crossref","unstructured":"Farokhnia M, Tazare J, Pince CL, Vi NB, Gray JC, Re III, Fiellin VL, Kranzler DA, Koob HR, G. F., Justice AC (2025) Glucagon-like peptide-1 receptor agonists but not dipeptidyl peptidase-4 inhibitors reduce alcohol intake. J. Clin. Investig.","DOI":"10.1172\/JCI188314"},{"key":"6980_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"OM Farr","year":"2016","unstructured":"Farr OM, Sofopoulos M, Tsoukas MA, Dincer F, Thakkar B, Sahin-Efe A, Filippaios A, Bowers J, Srnka A, Gavrieli A (2016) GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia 59:954\u2013965","journal-title":"Diabetologia"},{"issue":"1","key":"6980_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1017\/S0007114509991462","volume":"103","author":"KR Freeland","year":"2010","unstructured":"Freeland KR, Wilson C, Wolever TM (2010) Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 103(1):82\u201390","journal-title":"Br J Nutr"},{"issue":"8","key":"6980_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","volume":"72","author":"BF Grant","year":"2015","unstructured":"Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS (2015) Epidemiology of DSM-5 alcohol use disorder: results from the National epidemiologic survey on alcohol and related conditions III. JAMA Psychiatr 72(8):757\u2013766","journal-title":"JAMA Psychiatr"},{"key":"6980_CR28","doi-asserted-by":"crossref","unstructured":"Griffith AK, Martel MM, Fillmore MT (2024a) Attentional bias to alcohol-related cues: effects of menstrual cycle phase and sex differences. Psychopharmacol., 1\u201311","DOI":"10.1007\/s00213-024-06652-3"},{"issue":"6","key":"6980_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1037\/adb0000978","volume":"38","author":"AK Griffith","year":"2024","unstructured":"Griffith AK, Martel MM, Fillmore MT (2024b) Effect of menstrual cycle on rewarding properties of alcohol cues in women. Psychol Addict Behav 38(6):676","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"6980_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381","journal-title":"J Biomed Inform"},{"key":"6980_CR31","doi-asserted-by":"crossref","unstructured":"Hashizume C, Okuma K (2009) Fibersol\u00ae-2 resistant maltodextrin: Functional dietary fiber ingredient. SS Cho & P Samuel (Eds.), Fiber ingredients. CRC Press, pp 75\u201392","DOI":"10.1201\/9781420043853-9"},{"key":"6980_CR32","doi-asserted-by":"crossref","unstructured":"Heijboer AC, Frans A, Lomecky M, Blankenstein MA (2011) Analysis of glucagon-like peptide 1; what to measure? Clinica chimica acta. 412(13\u201314):1191\u20131194","DOI":"10.1016\/j.cca.2011.03.010"},{"key":"6980_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2024.4789","author":"CS Hendershot","year":"2025","unstructured":"Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Dermody SS, Prince MA, Jordan R (2025) Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.4789","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"6980_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.molmet.2015.09.007","volume":"4","author":"M Heni","year":"2015","unstructured":"Heni M, Kullmann S, Gallwitz B, H\u00e4ring H-U, Preissl H, Fritsche A (2015) Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans. Mol Metab 4(12):971\u2013976","journal-title":"Mol Metab"},{"issue":"4","key":"6980_CR35","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87(4):1409\u20131439","journal-title":"Physiol Rev"},{"issue":"1","key":"6980_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2337\/db18-0729","volume":"68","author":"MK Holt","year":"2019","unstructured":"Holt MK, Richards JE, Cook DR, Brierley DI, Williams DL, Reimann F, Gribble FM, Trapp S (2019) Preproglucagon neurons in the nucleus of the solitary tract are the main source of brain GLP-1, mediate stress-induced hypophagia, and limit unusually large intakes of food. Diabetes 68(1):21\u201333","journal-title":"Diabetes"},{"issue":"8","key":"6980_CR37","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1210\/en.2011-0174","volume":"152","author":"SE Kanoski","year":"2011","unstructured":"Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR (2011) Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and Exendin-4. Endocrinology 152(8):3103\u20133112","journal-title":"Endocrinology"},{"key":"6980_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159863","author":"MK Klausen","year":"2022","unstructured":"Klausen MK, Jensen ME, M\u00f8ller M, Le Dous N, Jensen A-M \u00d8, Zeeman VA, Johannsen C-F, Lee A, Thomsen GK, Macoveanu J (2022) Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.159863","journal-title":"JCI Insight"},{"issue":"3","key":"6980_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1124\/mol.110.065664","volume":"78","author":"C Koole","year":"2010","unstructured":"Koole C, Wootten D, Simms J, Valant C, Sridhar R, Woodman OL, Miller LJ, Summers RJ, Christopoulos A, Sexton PM (2010) Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening. Mol Pharmacol 78(3):456\u2013465","journal-title":"Mol Pharmacol"},{"issue":"8","key":"6980_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1176\/appi.ajp.20230488","volume":"180","author":"HR Kranzler","year":"2023","unstructured":"Kranzler HR (2023) Overview of alcohol use disorder. Am J Psychiatry 180(8):565\u2013572","journal-title":"Am J Psychiatry"},{"issue":"12","key":"6980_CR41","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41591-023-02634-8","volume":"29","author":"L Leggio","year":"2023","unstructured":"Leggio L, Hendershot CS, Farokhnia M, Fink-Jensen A, Klausen MK, Schacht JP, Simmons WK (2023) GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders. Nat Med 29(12):2993\u20132995","journal-title":"Nat Med"},{"issue":"2","key":"6980_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyae009","volume":"27","author":"X Li","year":"2024","unstructured":"Li X, Shi Z, Todaro DR, Pond T, Byanyima JI, Vesslee SA, Reddy R, Nanga RPR, Kass G, Ramchandani V (2024) Ketone supplementation dampens subjective and objective responses to alcohol: evidence from a preclinical rat study and a randomized, cross-over trial in healthy volunteers. Int J Neuropsychopharmacol 27(2):pyae009","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"6980_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091163","volume":"9","author":"C-Y Liu","year":"2014","unstructured":"Liu C-Y, Huang C-J, Huang L-H, Chen I-J, Chiu J-P, Hsu C-H (2014) Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One 9(3):e91163","journal-title":"PLoS One"},{"issue":"3","key":"6980_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nrendo.2016.142","volume":"13","author":"J Martel","year":"2017","unstructured":"Martel J, Ojcius DM, Chang C-J, Lin C-S, Lu C-C, Ko Y-F, Tseng S-F, Lai H-C, Young JD (2017) Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nat Rev Endocrinol 13(3):149\u2013160","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"6980_CR45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1530-0277.1993.tb00739.x","volume":"17","author":"CS Martin","year":"1993","unstructured":"Martin CS, Earleywine M, Musty RE, Perrine M, Swift RM (1993) Development and validation of the biphasic alcohol effects scale. Alcohol Clin Exp Res 17(1):140\u2013146","journal-title":"Alcohol Clin Exp Res"},{"key":"6980_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.599646","volume":"14","author":"VN Marty","year":"2020","unstructured":"Marty VN, Farokhnia M, Munier JJ, Mulpuri Y, Leggio L, Spigelman I (2020) Long-acting glucagon-like peptide-1 receptor agonists suppress voluntary alcohol intake in male wistar rats. Front Neurosci 14:599646","journal-title":"Front Neurosci"},{"issue":"11","key":"6980_CR47","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1177\/02698811211050567","volume":"35","author":"AM McNeill","year":"2021","unstructured":"McNeill AM, Monk RL, Qureshi A, Heim D (2021) Intoxication without anticipation: disentangling pharmacological from expected effects of alcohol. J Psychopharmacol 35(11):1398\u20131410","journal-title":"J Psychopharmacol"},{"issue":"10","key":"6980_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13441","volume":"29","author":"M Molina-Castro","year":"2024","unstructured":"Molina-Castro M, Seyedsadjadi N, Nieto D, Leggio L, Rowitz B, Pepino MY (2024) The glucagon-like peptide-1 and other endocrine responses to alcohol ingestion in women with versus without metabolic surgery. Addict Biol 29(10):e13441","journal-title":"Addict Biol"},{"issue":"8","key":"6980_CR49","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1037\/adb0000522","volume":"33","author":"R Monem","year":"2019","unstructured":"Monem R, Fillmore MT (2019) Alcohol administration reduces attentional bias to alcohol-related but not food-related cues: evidence for a satiety hypothesis. Psychol Addict Behav 33(8):677","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"6980_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","volume":"227","author":"ME Morean","year":"2013","unstructured":"Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O\u2019Malley SS (2013) The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology 227(1):177\u2013192","journal-title":"Psychopharmacology"},{"key":"6980_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD M\u00fcller","year":"2019","unstructured":"M\u00fcller TD, Finan B, Bloom S, D\u2019Alessio D, Drucker DJ, Flatt P, Fritsche A, Gribble F, Grill H, Habener J (2019) Glucagon-like peptide 1 (GLP-1). Mol Metab 30:72\u2013130","journal-title":"Mol Metab"},{"issue":"6","key":"6980_CR52","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1017\/S0007114515002524","volume":"114","author":"AC Nilsson","year":"2015","unstructured":"Nilsson AC, Johansson-Boll EV, Bj\u00f6rck IM (2015) Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: a randomised cross-over study in healthy middle-aged subjects. Br J Nutr 114(6):899\u2013907","journal-title":"Br J Nutr"},{"key":"6980_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3758\/s13428-018-01193-y","volume":"51","author":"J Peirce","year":"2019","unstructured":"Peirce J, Gray JR, Simpson S, MacAskill M, H\u00f6chenberger R, Sogo H, Kastman E, Lindel\u00f8v JK (2019) PsychoPy2: experiments in behavior made easy. Behav Res Methods 51:195\u2013203","journal-title":"Behav Res Methods"},{"issue":"12","key":"6980_CR54","doi-asserted-by":"publisher","first-page":"G1117","DOI":"10.1152\/ajpgi.00035.2013","volume":"304","author":"A Plamboeck","year":"2013","unstructured":"Plamboeck A, Veedfald S, Deacon CF, Hartmann B, Wettergren A, Svendsen LB, Meisner S, Hovendal C, Vilsb\u00f8ll T, Knop FK (2013) The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty. Am J Physiol-Gastrointest Liver Physiol 304(12):G1117\u2013G1127","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"issue":"1","key":"6980_CR55","doi-asserted-by":"publisher","first-page":"20998","DOI":"10.1038\/s41598-023-48267-2","volume":"13","author":"F Quddos","year":"2023","unstructured":"Quddos F, Hubshman Z, Tegge A, Sane D, Marti E, Kablinger AS, Gatchalian KM, Kelly AL, DiFeliceantonio AG, Bickel WK (2023) Semaglutide and tirzepatide reduce alcohol consumption in individuals with obesity. Sci Rep 13(1):20998","journal-title":"Sci Rep"},{"issue":"1","key":"6980_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1037\/adb0000005","volume":"29","author":"W Roberts","year":"2015","unstructured":"Roberts W, Fillmore MT (2015) Attentional bias to alcohol-related stimuli as an indicator of changes in motivation to drink. Psychol Addict Behav 29(1):63","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"6980_CR57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.2040-1124.2011.00163.x","volume":"3","author":"K Sakurai","year":"2012","unstructured":"Sakurai K, Lee EY, Morita A, Kimura S, Kawamura H, Kasamatsu A, Shiiba M, Yabe D, Yokote K, Miki T (2012) Glucagon-like peptide\u20101 secretion by direct stimulation of L cells with luminal sugar vs non\u2010nutritive sweetener. J Diabetes Invest 3(2):156\u2013163","journal-title":"J Diabetes Invest"},{"key":"6980_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2023.114111","volume":"263","author":"C Schulz","year":"2023","unstructured":"Schulz C, Vezzani C, Kroemer NB (2023) How gut hormones shape reward: a systematic review of the role of ghrelin and GLP-1 in human fMRI. Physiology & behavior 263:114111","journal-title":"Physiology & behavior"},{"key":"6980_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.774050","volume":"15","author":"OT Shevchouk","year":"2021","unstructured":"Shevchouk OT, Tufvesson-Alm M, Jerlhag E (2021) An overview of appetite-regulatory peptides in addiction processes; from bench to bed side. Frontiers in neuroscience 15:774050","journal-title":"Frontiers in neuroscience"},{"issue":"4","key":"6980_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061965","volume":"8","author":"RH Shirazi","year":"2013","unstructured":"Shirazi RH, Dickson SL, Skibicka KP (2013) Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward. PLoS One 8(4):e61965","journal-title":"PLoS One"},{"issue":"1","key":"6980_CR61","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.clinpsy.121208.131444","volume":"6","author":"AW Stacy","year":"2010","unstructured":"Stacy AW, Wiers RW (2010) Implicit cognition and addiction: a tool for explaining paradoxical behavior. Annu Rev Clin Psychol 6(1):551\u2013575","journal-title":"Annu Rev Clin Psychol"},{"issue":"6","key":"6980_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.68","volume":"5","author":"P Suchankova","year":"2015","unstructured":"Suchankova P, Yan J, Schwandt M, Stangl B, Caparelli E, Momenan R, Jerlhag E, Engel J, Hodgkinson C, Egli M (2015) The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence. Transl Psychiatry 5(6):e583-e583","journal-title":"Transl Psychiatry"},{"issue":"1","key":"6980_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1139\/H09-119","volume":"35","author":"J Tarini","year":"2010","unstructured":"Tarini J, Wolever TM (2010) The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35(1):9\u201316","journal-title":"Appl Physiol Nutr Metab"},{"key":"6980_CR64","unstructured":"Team R (2015) R. RStudio: integrated development environment for R. RStudio. Inc., Boston, MA, 14"},{"issue":"12","key":"6980_CR65","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1007\/s00125-015-3754-x","volume":"58","author":"JS Ten Kulve","year":"2015","unstructured":"Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Konrad RJ, Sloan JH, Drent ML, Diamant M (2015) Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia 58(12):2688\u20132698","journal-title":"Diabetologia"},{"issue":"11","key":"6980_CR66","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.2337\/dc16-2113","volume":"40","author":"JS Ten Kulve","year":"2017","unstructured":"Ten Kulve JS, Veltman DJ, Gerdes VE, Van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Drent ML, Diamant M, IJzerman RG (2017) Elevated postoperative endogenous GLP-1 levels mediate effects of Roux-en-Y gastric bypass on neural responsivity to food cues. Diabetes Care 40(11):1522\u20131529","journal-title":"Diabetes Care"},{"issue":"2","key":"6980_CR67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/adb.12295","volume":"21","author":"D Vall\u00f6f","year":"2016","unstructured":"Vall\u00f6f D, Maccioni P, Colombo G, Mandrapa M, J\u00f6rnulf JW, Egecioglu E, Engel JA, Jerlhag E (2016) The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents. Addict Biol 21(2):422\u2013437","journal-title":"Addict Biol"},{"issue":"12","key":"6980_CR68","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.2337\/db14-0849","volume":"63","author":"L van Bloemendaal","year":"2014","unstructured":"van Bloemendaal L, IJzerman RG, Kulve T, Barkhof JS, Konrad F, Drent RJ, Veltman ML, D. J., Diamant M (2014) GLP-1 receptor activation modulates appetite-and reward-related brain areas in humans. Diabetes 63(12):4186\u20134196","journal-title":"Diabetes"},{"issue":"9","key":"6980_CR69","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/dom.12506","volume":"17","author":"L van Bloemendaal","year":"2015","unstructured":"van Bloemendaal L, Veltman DJ, ten Kulve JS, Groot PF, Ruh\u00e9 HG, Barkhof F, Sloan JH, Diamant M, IJzerman RG (2015) Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon\u2010like peptide\u20101 receptor activation in humans. Diabetes Obes Metab 17(9):878\u2013886","journal-title":"Diabetes Obes Metab"},{"key":"6980_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2022.105667","volume":"137","author":"CC van Ruiten","year":"2022","unstructured":"van Ruiten CC, ten Kulve JS, van Bloemendaal L, Nieuwdorp M, Veltman DJ, Ijzerman RG (2022) Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial. Psychoneuroendocrinology 137:105667","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"6980_CR71","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1017\/S0007114511002194","volume":"106","author":"SP Verhoef","year":"2011","unstructured":"Verhoef SP, Meyer D, Westerterp KR (2011) Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br J Nutr 106(11):1757\u20131762","journal-title":"Br J Nutr"},{"issue":"1","key":"6980_CR72","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1038\/s41467-024-48780-6","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R (2024) Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nat Commun 15(1):4548","journal-title":"Nat Commun"},{"issue":"1","key":"6980_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1037\/a0028991","volume":"27","author":"J Weafer","year":"2013","unstructured":"Weafer J, Fillmore MT (2013) Acute alcohol effects on attentional bias in heavy and moderate drinkers. Psychol Addict Behav 27(1):32","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"6980_CR74","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1124\/jpet.110.176362","volume":"336","author":"D Wootten","year":"2011","unstructured":"Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, Christopoulos A, Sexton PM (2011) Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. J Pharmacol Exp Ther 336(2):540\u2013550","journal-title":"J Pharmacol Exp Ther"},{"issue":"23","key":"6980_CR75","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.3390\/nu14235063","volume":"14","author":"A Yanagimoto","year":"2022","unstructured":"Yanagimoto A, Matsui Y, Yamaguchi T, Hibi M, Kobayashi S, Osaki N (2022) Effects of ingesting both catechins and chlorogenic acids on glucose, incretin, and insulin sensitivity in healthy men: a randomized, double-blinded, placebo-controlled crossover trial. Nutrients 14(23):5063","journal-title":"Nutrients"},{"issue":"3","key":"6980_CR76","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/nu15030777","volume":"15","author":"A Yanagimoto","year":"2023","unstructured":"Yanagimoto A, Matsui Y, Yamaguchi T, Saito S, Hanada R, Hibi M (2023) Acute dose\u2013response effectiveness of combined catechins and chlorogenic acids on postprandial glycemic responses in healthy men: results from two randomized studies. Nutrients 15(3):777","journal-title":"Nutrients"},{"key":"6980_CR77","doi-asserted-by":"crossref","unstructured":"Yaribeygi H, Jamialahmadi T, Moallem SA, Sahebkar A (2021) Boosting GLP-1 by natural products. Nat Prod Hum Diseases: Pharmacol Mol Targets Therapeutic Benefits, 513\u2013522","DOI":"10.1007\/978-3-030-73234-9_36"},{"issue":"5","key":"6980_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.nutres.2015.03.004","volume":"35","author":"Z Ye","year":"2015","unstructured":"Ye Z, Arumugam V, Haugabrooks E, Williamson P, Hendrich S (2015) Soluble dietary fiber (Fibersol-2) decreased hunger and increased satiety hormones in humans when ingested with a meal. Nutr Res 35(5):393\u2013400","journal-title":"Nutr Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06980-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:02:31Z","timestamp":1765296151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06980-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":78,"alternative-id":["6980"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06980-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent prior to participation. Study procedures were approved by the University of North Carolina at Chapel Hill Institutional Review Board (IRB #24-1095).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Dr. Hendershot declares consultation and scientific advisory board roles for Apollo Therapeutics and Ely Lilly. The other authors have no conflicts of interest\/competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}